Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury

Journal of Ethnopharmacology

Volumn 151, Issue 3, 2014, Pages 1124-1132

  Wu, Jun Biao ^a   Ye, Shu Fang ^a   Liang, Chun Ling ^a   Li, Yu Cui ^a   Yu, Ying Jia ^b   Lai, Jie Mei ^a   Lin, Hui ^a   Zheng, Jie ^a   Zhou, Jiu Yao ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b The Cooperation of Chinese and Western Medicine Hospital in Guangzhou   (China)

Author keywords

Nephrotic syndrome; Podocyte; Qi Dan Fang; Renal function

Indexed keywords

ADR; ADRIAMYCIN; BLOOD UREA NITROGEN; BUN; CYSC; CYSTATION C; NEPHROTIC SYNDROME; PODOCYTE; QI-DAN FANG; RENAL FUNCTION; REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION; RT-PCR; SCR; SERUM CREATININE; THE MIXTURE OF RADIX ASTRAGALI MONGOLICI (RA) AND RADIX SALVIAE MILTIORRHIZAE (RSM);

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BCL-2-ASSOCIATED X PROTEIN; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DOXORUBICIN; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MALE; MEMBRANE PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; NEPHROTIC SYNDROME; PHYTOTHERAPY; PODOCYTES; PROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84895068726     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2013.12.028     Document Type: Article

References (50)

1. Y.M. Ahn, S.K. Kim, S.H. Lee, S.Y. Ahn, S.W. Kang, J.H. Chung, S.D. Kim, and B.C. Lee Renoprotective effect of Tanshinone IIA, an active component of Salvia miltiorrhiza, on rats with chronic kidney disease Phytother. Res.: PTR 24 2010 1886 1892
2. A. Bagga, and R.N. Srivastava Nephrotic syndrome and proteinuria Indian J. Pediatri. 69 2002 1053 1054 (Pubitemid 36069523)
3. T. Bertani, A. Poggi, R. Pozzoni, F. Delaini, G. Sacchi, Y. Thoua, G. Mecca, G. Remuzzi, and M.B. Donati Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events Lab. Invest.; A Journal of Technical Methods and Pathology 46 1982 16 23 (Pubitemid 12167012)
4. J.E. Chipuk, T. Kuwana, L. Bouchier-Hayes, N.M. Droin, D.D. Newmeyer, M. Schuler, and D.R. Green Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis Science 303 2004 1010 1014 (Pubitemid 38209704)
5. R.J. Coward, R.R. Foster, D. Patton, L. Ni, R. Lennon, D.O. Bates, S.J. Harper, P.W. Mathieson, and M.A. Saleem Nephrotic plasma alters slit diaphragm-dependent signaling and translocates nephrin, Podocin, and CD2 associated protein in cultured human podocytes J. Am. Soc. Nephrol. 16 2005 629 637 (Pubitemid 41725099)
6. J.R. Faria, M. Yamamoto, R.M. Faria, J. Kerbauy, and J.S. Oliveira Fludarabine induces apoptosis in chronic lymphocytic leukemia - the role of P53, Bcl-2, Bax, Mcl-1, and Bag-1 proteins Braz. J. Med. Biol. Res. 39 2006 327 333 (Pubitemid 43349467)
7. A. Fukuda, L.T. Wickman, M.P. Venkatareddy, S.Q. Wang, M.A. Chowdhury, J.E. Wiggins, K.A. Shedden, and R.C. Wiggins Urine Podocin:Nephrin mRNA Ratio (PNR) as a Podocyte Stress Biomarker Nephrol. Dial. Transplant.: Official Publication of the European Dialysis and Transplant Association - European Renal Association 27 2012 4079 4087
8. M. Gigante, P. Pontrelli, E. Montemurno, L. Roca, F. Aucella, R. Penza, G. Caridi, E. Ranieri, G.M. Ghiggeri, and L. Gesualdo CD2AP mutations are associated with sporadic nephrotic syndrome and focal segmental glomerulosclerosis (FSGS) Nephrol. Dial. Transplant.: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24 2009 1858 1864
9. S.L. Harris, and A.J. Levine The p53 pathway: positive and negative feedback loops Oncogene 24 2005 2899 2908 (Pubitemid 40638098)
10. D. Hirano, and S. Fujinaga Two dosing regimens for steroid therapy in nephrotic syndrome Pediatr. Nephrol. (online) 06 February 2013
11. E.M. Hodson, and J.C. Craig Corticosteroid therapy for steroid-sensitive nephrotic syndrome in children: dose or duration? J. Am. Soc. Nephrol. 24 2013 7 9
12. C. Holmberg, and H. Jalanko Congenital nephrotic syndrome of the finnish type - key to the mechanisms of proteinuria Duodecim; laaketieteellinen aikakauskirja 127 2011 1017 1025
13. Hosten, A.O., 1990. BUN and Creatinine. In: Walker, H.K., Hall, W.D., Hurst, J.W. (Eds.), Clinical Methods: The History, Physical, and Laboratory Examinations, third ed., Boston.
14. W.L. Hsiao, and L. Liu The role of traditional Chinese herbal medicines in cancer therapy - from TCM theory to mechanistic insights Planta Med. 76 2010 1118 1131
15. T. Ito, N. Seo, H. Yagi, T. Ohtani, Y. Tokura, M. Takigawa, and F. Furukawa Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/lpr mice J. Dermatol. Sci. 28 2002 198 210 (Pubitemid 34242654)
16. Y. Kaneko, and I. Narita Nephritis and nephrotic syndrome Nihon Jinzo Gakkai shi 55 2013 35 41
17. K.P. Kang, S.K. Park, D.H. Kim, M.J. Sung, Y.J. Jung, A.S. Lee, J.E. Lee, K.M. Ramkumar, S. Lee, M.H. Park, S.G. Roh, and W. Kim Luteolin ameliorates cisplatin-induced acute kidney injury in mice by regulation of p53-dependent renal tubular apoptosis Nephrol. Dial. Transplant.: Official Publication of the European Dialysis and Transplant Association - European Renal Association 26 2011 814 822
18. R. Kelsey Podocyte biology: protein network involved in maintaining kidney permeability Nat. Rev. Nephrol. 9 2013 64
19. L.M. Kovacevic, N. Puizina-Ivic, D. Ljutic, S.M. Brakus, D.K. Govorko, I. Jelicic, D. Miric, J. Resic, and M. Saraga-Babic Differences in epidermal thickness and expression of apoptosis regulatory proteins in the skin of patients with chronic renal failure and pruritus Acta Histochem. 115 2013 144 150
20. S. Li, C.X. Jun, H.J. Dong, Z.S. Gao, and M.J. Chun Comparisons different doses of Astragali membranaceus and Salvia miltiorrhiza in rats proteinuria Chin. J. New Drugs Clin. Rem. 19 2005 205 208
21. Y. Li, X. Bi, G. Zhu, Z. Han, Y. Ye, Y. Liang, L. Zhang, Z. Hao, G. Zeng, H. He, and W. Zhong Protective effect of glycyrrhizin on nephrotic syndrome induced by adriamycin in rats. Clinical and investigative medicine Med. Clin. Exp. 32 2009 229 238
22. J. Lin, H. Nie, A. Chou, S.-f. Ye, and J Zhou Effects of Qi-Dan Fang on renal function and serum lipid in nephrotic syndrome rats induced by adriamycin J. Pharm. Biomed. Sci. 24 2012 26 30
23. X. M, and F. JM The mechanism of Astragalus membranaceus in nephrotic syndrome Med. J. West China 21 2009 474 475
24. J. Mao, Y. Zhang, L. Du, Y. Dai, C. Yang, and L. Liang Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy Pediatr. Nephrol. 21 2006 1666 1675 (Pubitemid 44390831)
25. P.W. Mathieson The podocyte as a target for therapies - new and old. Nat. Rev. Nephrol. 8 2012 52 56
26. A. Meguid El Nahas, and A.K. Bello Chronic kidney disease: the global challenge Lancet 365 2005 331 340 (Pubitemid 40139112)
27. A. Meyrier, M.C. Condamin, and P. Simon Treatment with cyclosporine of adult idiopathic nephrotic syndrome resistant to corticosteroids and other immunosuppressants Transplant. Proc. 20 1988 259 261
28. T. Miyashita, and J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
29. G. Mollet, J. Ratelade, O. Boyer, A.O. Muda, L. Morisset, T.A. Lavin, D. Kitzis, M.J. Dallman, L. Bugeon, N. Hubner, M.C. Gubler, C. Antignac, and E.L. Esquivel Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome J. Am. Soc. Nephrol. 20 2009 2181 2189
30. P. Mundel, and S.J. Shankland Podocyte biology and response to injury J. Am. Soc. Nephrol. 13 2002 3005 3015 (Pubitemid 35386921)
31. H. Ozer, G. Yenicesu, S. Arici, M. Cetin, E. Tuncer, and A. Cetin Immunohistochemistry with apoptotic-antiapoptotic proteins (p53, p21, bax, bcl-2), c-kit, telomerase, and metallothionein as a diagnostic aid in benign, borderline, and malignant serous and mucinous ovarian tumors Diagn. Pathol. 7 2012 124
32. A. Pedrycz, K. Czerny, M. Wieczorski, and D. Hernik Hiponatremia during pregnancy with adriamycin-induced nephrotic syndrome in rats Ann. Univ. Mariae Curie Sklodowska Med. 58 2003 86 90
33. J.A. Pinto, and D.B. Brewer Morphometry of the glomeruli in puromycin aminonucleoside nephrotic syndrome J. Pathol. 1973 109 (Pxi)
34. N.G. Rajesh Nephrotic syndrome Paediatr. Child Health 22 2012 337 340
35. R. Ramadan, D. Faour, H. Awad, E. Khateeb, R. Cohen, A. Yahia, R. Torgovicky, R. Cohen, D. Lazari, H. Kawachi, and Z. Abassi Early treatment with everolimus exerts nephroprotective effect in rats with adriamycin-induced nephrotic syndrome Nephrol. Dial. Transplant.: Official Publication of the European Dialysis and Transplant Association - European Renal Association 27 2012 2231 2241
36. A. Rashikh, K.K. Pillai, S.J. Ahmad, M. Akhtar, and A.K. Najmi Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury J. Renin. Angiotensin Aldosterone Syst. 14 2013 14 22
37. J. Reiser, and S. Sever Podocyte biology and pathogenesis of kidney disease Annu. Rev. Med. 64 2013 357 366
38. Y.C. Shen The protective effects of Salvia miltiorrhiza on the warm ischemic kidney: experimental study in animals Chin. J. Surg. 26 759-761 1988 783
39. I. Simic, M. Tabatabaeifar, and F. Schaefer Animal models of nephrotic syndrome Pediatr. Nephrol. 28 2012 2079 2088
40. I. Skirnisdottir, B. Sorbe, and T. Seidal P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma Int. J. Gynecol. Cancer: Official Journal of the International Gynecological Cancer Society 11 2001 147 158 (Pubitemid 32381664)
41. A. Takeda, H. Ohgushi, F. Niimura, and H. Matsutani Long-term effects of immunosuppressants in steroid-dependent nephrotic syndrome Pediatr. Nephrol. 12 1998 746 750 (Pubitemid 28556796)
42. M. Tkaczyk, M. Nowicki, and J. Lukamowicz Increased cystatin C concentration in urine of nephrotic children Pediatr. Nephrol. 19 2004 1278 1280 (Pubitemid 39462431)
43. W. Wang, and S. Wang Nephrotic syndrome and the TCM treatment J. Tradit. Chin. Med. 24 2004 201 203 (Pubitemid 41238319)
44. L. Wei, R. Ye, T. Luan, R. Lu, and B. Chen Long-term effect of TCM decoctions in treatment of nephrotic syndrome J. Tradit. Chin. Med. 22 2002 83 86 (Pubitemid 41246381)
45. Y. WZ, G. GS, and H. XS Effect of astragale injection on serum lipids in nephrotic syndrome Pract. Pharm. Clin. Remedi. 14 2011 194 195
46. Y. Xing, J. Ding, Q. Fan, and N. Guan Diversities of podocyte molecular changes induced by different antiproteinuria drugs Exp. Biol. Med. 231 2006 585 593
47. W. Ye, X. Gong, J. Xie, J. Wu, X. Zhang, Q. Ouyang, X. Zhao, Y. Shi, and X. Zhang AChE deficiency or inhibition decreases apoptosis and p53 expression and protects renal function after ischemia/reperfusion Apoptosis 15 2010 474 487
48. S. Yilmaz, A. Atessahin, E. Sahna, I. Karahan, and S. Ozer Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity Toxicology 218 2006 164 171 (Pubitemid 41821347)
49. W. Yuan, J. Wang, and T. Wu Chinese herbal medicine Huangqi type formulations for nephrotic syndrome Cochrane Database Syst. Rev 2008
50. R. Zheng, Y. Deng, Y. Chen, J. Fan, M. Zhang, Y. Zhong, R. Zhu, and L. Wang Astragaloside IV attenuates complement membranous attack complex induced podocyte injury through the MAPK pathway Phytother. Res. 26 2012 892 898